| |
BASF Orgamol Pharma Solutions France SAS Saint-Vulbas, France
The site close to Lyon was inaugurated in 1994 by Orgamol and expanded with a second production building in 1999. Today the site runs more than 70 different chemical stages in the complete field of organic chemistry, including phosgenations and halogenations – with most of the productions dedicated as exclusives in a confidential and close customer relation.
 |
| Products |
|
Active ingredients, advanced intermediates, custom synthesis services for the pharmaceutical industry |
| |
| Assets |
| 2 production plants with a total reactor volume of 175 m3 cGMP
|
| |
| Technology |
| Organic chemistry, including phosgenations, low temperature reactions and halogenations |
| |
| Service |
| Commercial productions in the field of custom synthesis |
| |
|
|
|
 |
News |
| |
|
June 19, 2008: Leading the way in respect of quality standards for pharmaceutical excipients (english, deutsch) May 16, 2008: Pharmaceutical excipient for instant-release tablet coatings approved in USA (english, deutsch) April 30, 2008: BASF sells its Shreveport site and related contract manufacturing business to Dr. Reddy's Laboratories (english, deutsch)
|
|
 |
Product Search |
 |
 |
|